On remestemcel-L, two sides of the same point.
Something I heard SI say yesterday confirms what I have suspected for quite a while, that the EAP (Expanded Access Program) has been ongoing, it would have been rather inhumane to just stop, despite the cost. For the clinicians already supplying it I suspect it might be a fairly smooth transition one day to the next but probably a lot less paperwork for them, no more urgent EAP applications.
Then there is slide 18 of the AGM presentation, something that has been presented more than once. There would be a moderate pool of professionals in some hospitals who have been using remestemcel-L (as it is now known) for many years, up to a decade for some locations. I suspect the responses expressed are based on quite a few years exposure for most.
- Forums
- ASX - By Stock
- MSB
- Ann: Presentation to 2019 Annual General Meeting
Ann: Presentation to 2019 Annual General Meeting, page-2
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.11 |
Change
0.035(3.27%) |
Mkt cap ! $1.250B |
Open | High | Low | Value | Volume |
$1.08 | $1.11 | $1.07 | $2.350M | 2.157M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 46358 | $1.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 34504 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 32737 | 1.100 |
23 | 65986 | 1.095 |
22 | 177659 | 1.090 |
19 | 658949 | 1.085 |
9 | 391319 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.105 | 76153 | 20 |
1.110 | 115707 | 14 |
1.115 | 27845 | 5 |
1.120 | 156241 | 19 |
1.125 | 36795 | 6 |
Last trade - 14.20pm 13/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.10 |
  |
Change
0.035 ( 2.36 %) |
|||
Open | High | Low | Volume | ||
$1.08 | $1.11 | $1.07 | 479853 | ||
Last updated 14.39pm 13/06/2024 ? |
Featured News
MSB (ASX) Chart |